Billiontoone (NASDAQ:BLLN) SVP Sells $169,920.00 in Stock

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,416 shares of the business’s stock in a transaction that occurred on Thursday, September 24th. The shares were sold at an average price of $120.00, for a total transaction of $169,920.00. Following the transaction, the senior vice president directly owned 22,219 shares of the company’s stock, valued at approximately $2,666,280. This represents a 5.99% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Monday, September 21st, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $106.61, for a total transaction of $150,959.76.
• On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $97.54, for a total transaction of $138,116.64.
• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total transaction of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total value of $131,582.62.

Billiontoone Price Performance

NASDAQ:BLLN opened at $106.44 on Thursday. Billiontoone, Inc. has a 52-week low of $61.96 and a 52-week high of $150.44. The stock has a fifty day moving average of $107.92 and a 200 day moving average of $99.53. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69. The firm has a market capitalization of $5.02 billion and a price-to-earnings ratio of 152.06.

Billiontoone (NASDAQ:BLLN) last announced its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The business had revenue of $109.45 million for the quarter. On average, research analysts expect that Billiontoone, Inc. will post 0.83 EPS for the current fiscal year.

Hedge Funds Weigh In On Billiontoone

Several institutional investors and hedge funds have recently modified their holdings of BLLN. Integrated Wealth Concepts LLC bought a new position in Billiontoone in the 2nd quarter worth about $29,000. MCF Advisors LLC increased its holdings in shares of Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company’s stock worth $54,000 after purchasing an additional 344 shares in the last quarter. Thrive Wealth Management LLC purchased a new stake in shares of Billiontoone during the 2nd quarter valued at about $240,000. Caitong International Asset Management Co. Ltd purchased a new stake in Billiontoone in the fourth quarter worth approximately $230,000. Finally, Jasper Ridge Partners L.P. bought a new stake in shares of Billiontoone in the second quarter worth $615,000.

Analyst Upgrades and Downgrades

A number of research firms recently commented on BLLN. Canaccord Genuity Group started coverage on Billiontoone in a research note on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 target price on the stock. JPMorgan Chase & Co. decreased their price objective on Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a report on Thursday, August 6th. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Weiss Ratings restated a “sell (d+)” rating on shares of Billiontoone in a report on Friday, September 18th. Finally, BTIG Research decreased their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Seven research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $125.88.

Billiontoone Company Profile

BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.